Iqvia Holdings earnings were $1.4B for the trailing 12 months ending Sep 30, 2026, with 13.2% growth year over year. The latest IQV earnings report on Sep 30, 2026 announced Q3 2026 earnings of $350.0M, up 36.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IQV reported annual earnings of $1.4B, with -0.9% growth.
IQV past earnings growth
How has IQV's earnings growth performed historically?
On IQV's earnings call on Oct 27, 2026, Iqvia Holdings (NYSE: IQV) reported Q3 2026 earnings per share (EPS) of $2.13, up 9.79% year over year. Total IQV earnings for the quarter were $350.00 million. In the same quarter last year, Iqvia Holdings's earnings per share (EPS) was $1.94.
As of the last Iqvia Holdings earnings report, Iqvia Holdings is currently profitable. Iqvia Holdings's net profit (also called net income) for the twelve months ending Sep 30, 2026 was $1.39 billion, a 8.65% increase year over year.
What was IQV's earnings growth in the past year?
As of Iqvia Holdings's earnings date in Oct 27, 2026, Iqvia Holdings's earnings has grown 13.22% year over year. This is 1.65 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 11.57%. IQV earnings in the past year totalled $1.39 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.